Joseph A. Fix
Direktor/Vorstandsmitglied bei CritiTech, Inc.
Profil
Joseph A.
Fix is currently the Director at CritiTech, Inc. He previously worked as the Associate Director-Biological Sciences at ALZA Corp., Principal at Merck & Co., Inc., President & Chief Operating Officer at CyDex Pharmaceuticals, Inc., Chief Operating Officer & EVP at NanoSystems LLC, and President & Chief Technology Officer at Yamanouchi Pharma SA. Dr. Fix holds an MBA from Pepperdine University and an undergraduate degree from the University of Kansas.
Aktive Positionen von Joseph A. Fix
| Unternehmen | Position | Beginn |
|---|---|---|
CritiTech, Inc.
 CritiTech, Inc. BiotechnologyHealth Technology CritiTech, Inc. operates as a drug development company. It offers human and veterinarian products. The company also provides drug feasibility, drug optimization and API drug manufacturing and supply agreement services. CritiTech was founded by Sam D. Campbell, Valentino J. Stella and Bala Subramaniam in 1997 and is headquartered in Lawrence, KS. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Joseph A. Fix
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Yamanouchi Pharma SA
 Yamanouchi Pharma SA Pharmaceuticals: MajorHealth Technology Yamanouchi Pharma SA manufactures and distributes pharmaceutical products. It operates as a subsidiary of Astellas Pharma, Inc. The company was founded in 1993 and is headquartered in Madrid, Spain. | Präsident | - |
NanoSystems LLC
 NanoSystems LLC Information Technology ServicesTechnology Services NanoSystems LLC developed software solutions for surface inspection systems. The company was headquartered in Atlanta, GA. | Geschäftsführer | - |
| ALZA CORPORATION | Corporate Officer/Principal | - |
CyDex Pharmaceuticals, Inc.
 CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Präsident | - |
Ausbildung von Joseph A. Fix
| University of Kansas | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
CritiTech, Inc.
CritiTech, Inc. BiotechnologyHealth Technology CritiTech, Inc. operates as a drug development company. It offers human and veterinarian products. The company also provides drug feasibility, drug optimization and API drug manufacturing and supply agreement services. CritiTech was founded by Sam D. Campbell, Valentino J. Stella and Bala Subramaniam in 1997 and is headquartered in Lawrence, KS. | Health Technology |
CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Health Technology |
NanoSystems LLC
NanoSystems LLC Information Technology ServicesTechnology Services NanoSystems LLC developed software solutions for surface inspection systems. The company was headquartered in Atlanta, GA. | Technology Services |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Yamanouchi Pharma SA
Yamanouchi Pharma SA Pharmaceuticals: MajorHealth Technology Yamanouchi Pharma SA manufactures and distributes pharmaceutical products. It operates as a subsidiary of Astellas Pharma, Inc. The company was founded in 1993 and is headquartered in Madrid, Spain. | Health Technology |
